Spotlight Series: Khiron Life Sciences Revisited

Our first recurring guest on our Spotlight Series is that of Chris Naprawa, whom is now the Chairman of Khiron Life Sciences (TSXV: KHRN), a Colombia-based international medical cannabis and CBD operator. After being featured on the first ever edition of the Spotlight Series, Chris has returned to discuss the international milestones as well as the latest developments of the firm.

Within, Naprawa addresses the recent milestone of achieving 1,000 medical patients within Colombia, and what that ultimately means for the balance sheet and income statement of the company. He then goes on discuss with us his take on the international markets, the significance of recent developments made by the company, and the firms outlook on international opportunities as they relate to North America and the rest of the world.

Finally, we address the current state of the cannabis market – the sector rotations we’ve seen as of late, as well as the impact that this rotation has on the fundamentals of cannabis firms at large. Watch the video below to get the full details of these discussions and more.


FULL DISCLOSURE: Khiron Life Sciences is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Khiron Life Sciences on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

Questcorp Begins 600 Metre Phase 2B Drill Program at La Union

Selkirk Copper Wraps 54,579 Metre Phase 2 Program at Minto, Hits 5.97% Copper Equivalent

Related News

Khiron Life Sciences Sees CFO Resign, Appoints Third-Party Interim

Khiron Life Sciences Corp. (TSXV: KHRN) announced on Friday after the closing bell that its...

Monday, October 4, 2021, 10:41:00 AM

Khiron Life Sciences X Nimbus Health

Khiron Life Sciences (TSXV: KHRN, OTCQX: KHRNF, Frankfurt: A2JMZC) is the latest cannabis company to...

Sunday, August 16, 2020, 09:00:00 AM

Khiron Life Sciences Receives Authorization For The Sale Of High-CBD Medical Cannabis In Peru

Khiron Life Sciences (TSXV: KHRN) announced this morning that it now has access to yet...

Thursday, July 23, 2020, 08:59:43 AM

Khiron Signs Exclusive Partnership with Rappi, The Amazon Of South America

Khiron Life Sciences (TSXV: KHRN) this morning announced the significant development of establishing an exclusive...

Friday, September 4, 2020, 08:17:02 AM

The Deep Dive Spotlight Series: Chris Naprawa of Khiron Life Sciences

The Deep Dive is stepping up our programming. We’re upgrading our Canadian small cap coverage...

Saturday, June 6, 2020, 09:00:00 AM